The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine

Exclusion Criteria

• •Those who are diagnosed with primary headaches (exception: low-frequency intermittent tension type headaches) and secondary headaches in addition to migraine headaches
• •Those who are diagnosed with medication overuse headache in addition to migraine headaches
• •Pregnant or lactating of women within 6months
• •Among female subjects who are likely to be pregnant, those who disagree to contraception in a medically permitted manner during this clinical trial period. \*Medically permitted contraception: condom, Oral contraception that lasted for at least 3 months, contraceptive injection, contraceptive implant, intrauterine device, etc
• •Patients with mental illness who can interfere with their participation in the study.
• •In the case where medical devices for clinical trials cannot be applied due to being sensitive to orbital nerve stimulation.
• •Patients with a history of drug or alcohol abuse
• •Those who participated in other clinical trials within 30 days of screening.